The Serious Fraud Office (SFO) has today (22 February) ended investigations into two landmark cases involving Rolls-Royce and GlaxoSmithKline, prompting scepticism from white-collar lawyers.
Despite agreeing a £497.3m January 2017 deferred prosecution agreement (DPA) with the car manufacturer, the SFO has pulled its bribery and corruption probe into Rolls-Royce following a ‘detailed review of the available evidence’.
